Skip to content
Menu

Oncolytics Biotech Inc. ONC.TO

Full chart Compare
Set alert

Price alert · ONC.TO

All alert types
1.42 0.00 (+0.00%)

As ofAug 22, 2025, 4:00 PM EDT

1.39 Day range 1.44
0.45 52-week range 18.60
Market cap
142.25M
Shares out
77.07M
Forward P/E
-3.07
50-day average
1.45
200-day average
1.43
Enterprise value
89.44M
Price / book
3.49
Volume
109.63K
Avg volume
144.82K
Open
1.42
Previous close
1.42
Day's range
1.39 – 1.44
52-week range
0.45 – 18.60
Beta
1.51

 

No chart data for this range yet.

Key statistics

Free cash flow
-15.77M
Total cash
24.85M
Total debt
1.12M
Return on equity
-138.22%
Short % of float
0.61%

About Oncolytics Biotech Inc.

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on ONC.TO — it syncs with the Stock Master app.

Institution ownership

ONC.TO institution ownership
Holder% heldSharesValueReported
International Assets Investment Management, LLC0.26%198,400255.94KJun 29, 2024
Seeds Investor LLC 0.25%189,941245.02KSep 29, 2024
Goldman Sachs Group Inc0.11%84,998109.65KSep 29, 2024
Royal Bank of Canada0.10%74,54696.16KSep 29, 2024
Citadel Advisors Llc0.10%79,249102.23KSep 29, 2024
Commonwealth Equity Services, LLC0.08%61,11478.84KSep 29, 2024

Fund ownership

ONC.TO fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.05%41,94254.10KOct 30, 2024